On group sequential procedures under variance heterogeneity

Hussein, A.; Carriere, K. C.
April 2005
Statistical Methods in Medical Research;Apr2005, Vol. 14 Issue 2, p121
Academic Journal
journal article
In this paper, we consider group sequential procedures for clinical trials under variance heterogeneity. Group sequential procedures typically involve small samples at each interim analysis. We advocate Welch's correction for variance heterogeneity, and present a natural application of the significance level method for such situations. Currently available procedures are based on a large sample method, with no allowance for corrections of heterogeneity. Unless the sample size is large, the results are not valid. On the basis of simulation studies, comparing their abilities to control Type I error rates, we recommend using Welch's correction for sequential trials involving small samples under variance heterogeneity.


Related Articles

  • Clinical Trials in New Europe. DOIG, AL // Bio-IT World;Jan2009, Vol. 8 Issue 1, p13 

    The article presents an outlook for clinical trials in New Europe for 2009. The collapse of the Soviet Union is cited as one of the major factors which contributed to the emergence of new opportunity for clinical trials in Europe. An overview of the report from Insight Pharma Reports entitled...

  • Relevance of the clinical impact factor. Blitzkow, Gilson; Estrela, Carlos // Dental Press Endodontics;Jan-Apr2015, Vol. 5 Issue 1, p5 

    The author discusses the importance of systematic literature reviews to analyze clinical impact factors and select accurate and appropriate articles.

  • A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. Thabane, Lehana; Mbuagbaw, Lawrence; Zhang, Shiyuan; Samaan, Zainab; Marcucci, Maura; Chenglin Ye; Thabane, Marroon; Giangregorio, Lora; Dennis, Brittany; Kosa, Daisy; Debono, Victoria Borg; Dillenburg, Rejane; Fruci, Vincent; Bawor, Monica; Juneyoung Lee; Wells, George; Goldsmith, Charles H. // BMC Medical Research Methodology;2013, Vol. 13 Issue 1, p1 

    Background: Sensitivity analyses play a crucial role in assessing the robustness of the findings or conclusions based on primary analyses of data in clinical trials. They are a critical way to assess the impact, effect or influence of key assumptions or variations-such as different methods of...

  • The Cochrane Collaboration at 10: kudos and challenges.  // CMAJ: Canadian Medical Association Journal;9/28/2004, Vol. 171 Issue 7, p701 

    Introduces a series of articles related to the Cochrane Collaboration which compiled all randomized clinical trials in the perinatal field of medicine. Outcome of the collaboration in its first 10 years; Problem with the manipulation of research objectives to yield better results.

  • Data Based Predictions. Jones, Michelle; Jones, Stephen // Applied Clinical Trials;Mar2008, Vol. 17 Issue 3, p40 

    The article discusses a more informative approach to selection of countries and investigators for clinical trials in the U.S. The approach is based on the analysis of past performance and how the review of epidemiological and demographic data can help identify the golden site profile. The...

  • Europe Puts Renewed Emphasis on Patient Communication. Ward, Philip // Applied Clinical Trials;Apr/May2014, Vol. 23 Issue 4/5, p16 

    Information about the second workshop of the European Patients' Academy on Therapeutic Innovation (EUPATI) held in Warsaw, Poland is presented. The workshop is said to draw on the group's social research work involving patients and citizens across Europe and to provide details about successful...

  • Oncology Trial Comparator Drug Reimbursement: A Canadian Perspective. Deakin, Denise // Applied Clinical Trials;Apr/May2014, Vol. 23 Issue 4/5, p32 

    The article examines the Canadian comparator reimbursement climate to better inform trial expansion decisions. The author talks about the importance of comparators in cancer trials in the country. Also tackled is the potential for Canada to be a prospective region for the expansion of both early...

  • Engaging Tomorrow's Volunteers Through Museum Learning. Getz, Kenneth A. // Applied Clinical Trials;Jun/Jul2014, Vol. 23 Issue 6/7, p18 

    The article discusses the efforts to provide outreach and education to inform patients and the public about the clinical research process. The author reveals that the National and international polls conducted by the Center for Information and Study on Clinical Research Participation (CISCRP)...

  • Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified. Claudia Castañeda; Natividad Neri; Sergio Cleto; Alejandra Talavera; Martha González; Judith Huerta-Guzmán; M. Nambo // Medical Oncology;Sep2008, Vol. 25 Issue 3, p360 

    Abstract  We performed a controlled clinical trial to define the use of a brief therapy: CMED (cyclophosphamide, etoposide, methotrexate, and dexamethasone) compared with standard CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of peripheral T-cell...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics